Aclarion, Inc. $ACON
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
This page is still filling in. We publish more sections as filings are processed.
Snapshot
- Exchange
- Nasdaq Capital Market
- Sector
- Services-Medical Laboratories
- Headquarters
- Broomfield, CO
- Fiscal year end
- December 31
- Shares outstanding
- 2,882,371 [10-Q 2026-08-06]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | $46.3K | −$5.60M | −$5.30M | $16.29M | [10-Q 2026-08-06] |
| FY ended Dec 2025 | $75.7K | −$7.23M | −$7.16M | $12.02M | [10-K 2026-03-18] |
| FY ended Dec 2024 | $45.7K | −$6.99M | −$5.27M | $453.7K | [10-K 2026-03-18] |
- Quarterly cash burn
- −$2.65M
- Cash runway Estimate
- ~18.4 months
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2024-11-14 | 10,431,159 | [10-Q 2024-11-14] |
| 2025-04-09 | 582,371 | [10-K 2025-04-09] |
| 2025-05-15 | 582,371 | [10-Q 2025-05-15] |
| 2025-08-14 | 582,371 | [10-Q 2025-08-14] |
| 2025-11-10 | 671,371 | [10-Q 2025-11-12] |
| 2026-03-17 | 2,282,371 | [10-K 2026-03-18] |
| 2026-05-11 | 2,462,250 | [10-Q 2026-05-13] |
| 2026-08-04 | 2,882,371 | [10-Q 2026-08-06] |
- Shelf registration
- S-3 filed 2025-04-25; declared effective 2025-05-05 [S-3 2025-04-25]
Listing status
Current status: 1 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2024-10-11. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.
| Date | Event | Details | Deadline | Filing |
|---|---|---|---|---|
| 2024-10-11 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2024-10-11] |
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-08-17 | Williams Amanda M | buy | 5,857 | $2.73 | [4 2026-08-19] |
| 2026-08-14 | Gould Gregory A | buy | 10,000 | $2.45 | [4 2026-08-18] |
| 2026-08-13 | Bond Ryan | buy | 21,122 | $2.37 | [4 2026-08-17] |
| 2026-08-13 | Wesemann William | buy | 2,150 | $2.34 | [4 2026-08-17] |
| 2026-08-13 | Neal David K | buy | 7,500 | $2.40 | [4 2026-08-17] |
| 2026-08-13 | Ness Brent | buy | 5,234 | $2.31 | [4 2026-08-17] |
| 2026-06-11 | Bond Ryan | grant | 55,000 | — | [4 2026-06-12] |
| 2026-06-11 | Sequira Amanda Mae | grant | 20,000 | — | [4 2026-06-12] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-08-06 | 10-Q | Quarterly report |
| 2026-06-04 | 8-K | Shareholder vote results |
| 2026-05-13 | 10-Q | Quarterly report |
| 2026-04-27 | DEF 14A | Proxy statement |
| 2026-04-22 | 8-K | Other events |
| 2026-04-03 | PRE 14A | Proxy statement |
| 2026-03-25 | 13G | Beneficial ownership report (5%+ holder) |
| 2026-03-19 | 8-K | Material agreement entered; Change to security holder rights; Charter, bylaws or fiscal year change |
| 2026-03-18 | 10-K | Annual report |
| 2026-01-13 | 8-K | Regulation FD disclosure |
| 2026-01-09 | 8-K | Material agreement entered |
| 2026-01-09 | 424B5 | Prospectus or prospectus supplement |
Alerts for $ACON
Email me when Aclarion, Inc. files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.